Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Dna X (SONM) Other Operating Expenses (2018 - 2025)

Dna X filings provide 8 years of Other Operating Expenses readings, the most recent being -$11.9 million for Q4 2025.

  • On a quarterly basis, Other Operating Expenses rose 54.75% to -$11.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.7 million, a 80.87% increase, with the full-year FY2024 number at -$14.7 million, down 268.21% from a year prior.
  • Other Operating Expenses hit -$11.9 million in Q4 2025 for Dna X, down from $2.5 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $6.4 million in Q2 2024 to a low of -$26.2 million in Q4 2024.
  • Median Other Operating Expenses over the past 5 years was $2.5 million (2024), compared with a mean of $736900.0.
  • The widest YoY moves for Other Operating Expenses: up 252.27% in 2024, down 959.0% in 2024.
  • Dna X's Other Operating Expenses stood at $4.7 million in 2021, then crashed by 67.68% to $1.5 million in 2022, then soared by 100.72% to $3.1 million in 2023, then plummeted by 959.0% to -$26.2 million in 2024, then skyrocketed by 54.75% to -$11.9 million in 2025.
  • The last three reported values for Other Operating Expenses were -$11.9 million (Q4 2025), $2.5 million (Q3 2025), and $3.4 million (Q2 2025) per Business Quant data.